This inventor holds 1 USPTO granted patent. Top assignee: Rudjer Boskovic Institute. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Slovenko Polanc: Innovator in Tumor Treatment
Introduction
Slovenko Polanc is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative work focuses on developing compounds that can effectively combat various types of cancer.
Latest Patents
Slovenko Polanc holds a patent for "Analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and N-acyl derivatives for tumour treatment." This invention refers to analogues of 1,3-bis(4-nitrophenyl)triazenes, which demonstrate cytotoxicity at very low concentrations (IC0.22 to 12.8 µM) and exhibit good solubility. These compounds can be utilized in the treatment of tumor patients either as standalone drugs or in combination with other cytostatics.
Career Highlights
Slovenko Polanc is affiliated with the Ruđer Bošković Institute, where he conducts his research and development activities. His work has been instrumental in advancing the understanding and treatment of tumors through innovative pharmaceutical solutions.
Collaborations
He collaborates with esteemed colleagues such as Maja Osmak and Tamara Cimbora Zovko, contributing to a dynamic research environment focused on cancer treatment.
Conclusion
Slovenko Polanc's contributions to the field of tumor treatment through his patented innovations highlight his role as a significant figure in pharmaceutical research. His work continues to pave the way for new therapeutic options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile